Laurion Capital Management LP Amarin Corp Plcuk Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $351,808 - $607,936	-73,600 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$4.0 - $21.53 $294,400 - $1.58 Million	73,600 New	73,600 $294,000
Q3 2019 Nov 13, 2019	SELL	$13.89 - $23.16 $126,232 - $210,478	-9,088 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$16.27 - $20.51 $147,861 - $186,394	9,088 New	9,088 $176,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.